Left ventricular diastolic function improvement by carvedilol therapy in advanced heart failure

Journal of Cardiovascular Pharmacology

Volumn 45, Issue 6, 2005, Pages 563-568

  Palazzuoli, Alberto ^a,b   Quatrini, Ilaria ^a   Vecchiato, Lucia ^a   Calabria, Paolo ^a   Gennari, Luigi ^a   Martini, Giuseppe ^a   Nuti, Ranuccio ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Carvedilol; Diastolic filling; Echocardiography; Heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; DOPPLER ECHOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HEART VENTRICULOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

AGED; ANALYSIS OF VARIANCE; CARBAZOLES; DIASTOLE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PROPANOLAMINES; VENTRICULAR FUNCTION, LEFT;

EID: 19544374641     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000159880.12067.34     Document Type: Article

References (31)

1. McMurray JJ. Major beta blocker mortality trials in chronic heart failure: a critical review. Heart. 1999;82(Suppl 4):14-22.
2. Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure: a meta analysis of randomized clinical trials. J Am Coll Cardiol. 1997;30:27-34.
3. Lowes BD, Gill EA, Abraham WT, et al. Effects of carvedilol on left ventricular mass chamber geometry and mitral regurgitation in chronic heart failure. Am J Cardiol. 1999;83:1201-1205.
4. Sharpe N, Doughty RN. Left ventricular remodelling and improved long-term outcomes in chronic heart failure. Eur Heart J. 1998;(Suppl B): 36-39.
5. Macdonald PS, Keogh AM, Aboyoun CL, et al. Tolerability and efficacy of carvedilol in patients with NYHA class IV heart failure. J Am Coll Cardiol. 1999;33:924-931.
6. Bristow MR. Beta-adrenergic receptor blockade in chronic heart failure. Circulation. 2000;101:558-569.
7. Ohno M, Cheng C-P, Little WC. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation. 1994;89:2241-2250.
8. Pinamonti B, Di Lenarda A, Sinagra G, et al. Restrictive filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical echocardiographic and hemodynamic correlations and prognostic implications. J Am Coll Cardiol. 1993;22:808-815.
9. Xie GY, Berk MR, Smith MD, et al. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol. 1994;24:132-139.
10. Schiller NB, Shah PN, Crawford M, et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358-367.
11. Devereux LB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparision to necropsy findings. Am J Cardiol. 1986;57:450-458.
12. Wahr DW, Wang YS, Schiller NB. Left ventricular volumes determined by two dimensional echocardiography in a normal adult population. J Am Coll Cardiol. 1983;1:863-868.
13. Goodman DJ, Harrison DC, Popp RL. Echocardiographic features of primary pulmonary hypertension. Am J Cardiol. 1974;33:438-443.
14. Appleton CP, Hatle LK. The natural history of left ventricular filling abnormalities: assessment by two dimensional and Doppler echocardiography. Echocardiography. 1992;9:437-457.
15. Eichhorn EJ, Grayburn PA. Beta-blocker improvement in diastolic performance: the yin and the yang of ventricular function changes. Am Heart J. 2000;139:584-586.
16. Ohno M, Cheng C-P, Little WC. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation. 1994;89:2241-2250.
17. Bellenger NG, Rajappan K, Rahman SL, et al. CHRISTMAS Study Steering Committee and Investigators. Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study. Heart. 2004;90:760-764.
18. Paumbokian SV, Aminbakhsh A, Thompson CR, et al. Carvedilol improves functional class in patients with severe left ventricular dysfunction referred for heart transplantation. Clin Transplant. 1999; 13:426-431.
19. Quaife RA, Gilbert EM, Christian PE, et al. Effects of carvedilol on systolic and diastolic left ventricular function in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Am J Cardiol. 1996;78: 779-784.
20. Andersson B, Caidahl K, Di Lenarda A, et al. Changes in early and late diastolic filling patterns induced by long-term adrenergic beta blockade in patients with idiopathic dilated cardiomyopathy. Circulation. 1996;94: 673-682.
21. Bergstrom A, Andersson B, Edner M, et al. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Eur J Heart Fail. 2004;6:453-461.
22. Palazzuoli A, Carrera A, Calabria P, et al. Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure. Am Heart J. 2004;147:73-79.
23. Bristow MR. Beta-adrenergic receptor blockade in chronic heart failure. Circulation. 2000;101:558-569.
24. Senzaki H, Paolocci N, Gluzband YA, et al. Beta-blockade prevents sustained metalloproteinase activation and diastolic stiffness induced by angiotensin II combined with evolving cardiac dysfunction. Circ Res. 2000;86:807-815.
25. Wei S, Chow LT, Sanderson JE. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction. J Am Coll Cardiol. 2000;36:276-281.
26. Gupta RC, Shimoyama H, Tanimura M, et al. SR Ca(2+)-ATPase activity and expression in ventricular myocardium of dogs with heart failure. Am J Physiol. 1997;273:12-18.
27. Morgan JP. Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med. 1991;325:625-628.
28. Najajima T, Ma J, Iida H, et al. Inhibitory effects of carvedilol on calcium channels in vascular smooth muscle cells. Jpn Heart J. 2003;44:963-978.
29. Reiken S, Wehrens XH, Vest JA, et al. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation. 2003;107:2395-2397.
30. Koshimizu TA, Tsujimoto G, Hirasawa A, et al. Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors. Cardiovasc Res. 2004;63: 662-672.
31. Poole-Wilson PA, Swedberg K, Cleland JG, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomized controlled trial. Lancet. 2003;362:7-13.